phenytoin has been researched along with Arthritis, Rheumatoid in 16 studies
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate efficacy of phenytoin in modifying the course of rheumatoid arthritis (RA) by comparing it to gold (auranofin) and chloroquine." | 9.08 | Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. ( Ahmed, N; Askar, MA; Kumar, TR; Menon, GN; Naidu, MU; Rao, UR; Sarada, P; Shantaram, V; Shobha, U; Venubabu, K, 1995) |
| "In an open study, thirty-five patients with active rheumatoid arthritis were treated with phenytoin." | 9.07 | Evaluation of phenytoin in rheumatoid arthritis--an open study. ( Anuradha, RT; Naidu, MU; Ramesh Kumar, T; Rao, UR, 1991) |
| "The anticonvulsant drug phenytoin has several interesting immunological properties which could theoretically be of benefit in the treatment of rheumatoid arthritis." | 9.06 | Pilot study of phenytoin in rheumatoid arthritis. ( Clark, B; Macfarlane, DG; Panayi, GS, 1986) |
| "Phenytoin has known immunosuppressive properties, and a recent pilot study has indicated that it may have a second line effect in rheumatoid arthritis (RA)." | 9.06 | Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. ( Capell, HA; Fraser, SM; Hunter, JA; Richards, IM, 1987) |
| "In a prospective open study, 18 patients with active rheumatoid arthritis were treated with phenytoin (300 mg/day) for 32 weeks." | 7.67 | Phenytoin in rheumatoid arthritis. ( Grindulis, KA; Nichol, FE; Oldham, R, 1986) |
| "To evaluate efficacy of phenytoin in modifying the course of rheumatoid arthritis (RA) by comparing it to gold (auranofin) and chloroquine." | 5.08 | Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. ( Ahmed, N; Askar, MA; Kumar, TR; Menon, GN; Naidu, MU; Rao, UR; Sarada, P; Shantaram, V; Shobha, U; Venubabu, K, 1995) |
| "In an open study, thirty-five patients with active rheumatoid arthritis were treated with phenytoin." | 5.07 | Evaluation of phenytoin in rheumatoid arthritis--an open study. ( Anuradha, RT; Naidu, MU; Ramesh Kumar, T; Rao, UR, 1991) |
| "The anticonvulsant drug phenytoin has several interesting immunological properties which could theoretically be of benefit in the treatment of rheumatoid arthritis." | 5.06 | Pilot study of phenytoin in rheumatoid arthritis. ( Clark, B; Macfarlane, DG; Panayi, GS, 1986) |
| "Phenytoin has known immunosuppressive properties, and a recent pilot study has indicated that it may have a second line effect in rheumatoid arthritis (RA)." | 5.06 | Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. ( Capell, HA; Fraser, SM; Hunter, JA; Richards, IM, 1987) |
| "In a prospective open study, 18 patients with active rheumatoid arthritis were treated with phenytoin (300 mg/day) for 32 weeks." | 3.67 | Phenytoin in rheumatoid arthritis. ( Grindulis, KA; Nichol, FE; Oldham, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parada-Turska, J | 1 |
| Nowicka-Stążka, P | 1 |
| Majdan, M | 1 |
| Jabłoński, M | 1 |
| Turski, WA | 1 |
| Rzeski, W | 1 |
| Hart, C | 1 |
| Kinney, MO | 1 |
| McCarron, MO | 1 |
| Furst, DE | 1 |
| Bobrove, AM | 1 |
| Isobe, T | 1 |
| Tomita, M | 1 |
| Matsumoto, J | 1 |
| Itoh, T | 1 |
| Fujita, T | 1 |
| Rao, UR | 2 |
| Naidu, MU | 2 |
| Kumar, TR | 1 |
| Shobha, U | 1 |
| Askar, MA | 1 |
| Ahmed, N | 1 |
| Sarada, P | 1 |
| Venubabu, K | 1 |
| Shantaram, V | 1 |
| Menon, GN | 1 |
| Ramesh Kumar, T | 1 |
| Anuradha, RT | 1 |
| Grindulis, KA | 2 |
| Nichol, FE | 2 |
| Oldham, R | 2 |
| Macfarlane, DG | 1 |
| Clark, B | 1 |
| Panayi, GS | 1 |
| Richards, IM | 1 |
| Fraser, SM | 1 |
| Hunter, JA | 1 |
| Capell, HA | 1 |
| Harpey, JP | 1 |
| Moore, DS | 1 |
| Nally, FF | 1 |
| Stern, LZ | 1 |
| Gruener, R | 1 |
| Amundsen, P | 1 |
| Markkanen, T | 1 |
| Peltola, O | 1 |
| Naess, K | 1 |
1 review available for phenytoin and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Lupus-like syndromes induced by drugs.
Topics: Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Chlorpromazine; DNA, Single-Stra | 1974 |
4 trials available for phenytoin and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Topics: Adult; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Chloroquine; Do | 1995 |
Evaluation of phenytoin in rheumatoid arthritis--an open study.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Phenytoin | 1991 |
Pilot study of phenytoin in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Phe | 1986 |
Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Gold; Humans; Phenytoin; Random Allocation; Rheumatoid Factor | 1987 |
11 other studies available for phenytoin and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Anti-epileptic drugs inhibit viability of synoviocytes in vitro.
Topics: Animals; Anticonvulsants; Arthritis, Rheumatoid; Carbamazepine; Cell Proliferation; Cell Survival; C | 2013 |
Posterior reversible encephalopathy syndrome and oral methotrexate.
Topics: Aged; Anticonvulsants; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Cell Count; Brain; Female; | 2012 |
Use of ibuprofen in unusual circumstances.
Topics: Arthritis, Rheumatoid; Aspirin; Bartter Syndrome; Cyclooxygenase Inhibitors; Digoxin; Drug Hypersens | 1984 |
Possible beneficial effects of phenytoin for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Humans; Phenytoin | 1983 |
Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
Topics: Adolescent; Aged; Anticonvulsants; Arthritis, Rheumatoid; Female; Humans; Infectious Mononucleosis; | 1983 |
Phenytoin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Humans; Phenytoin | 1988 |
Phenytoin in rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Blood Viscosity; C-Reactive Protein; F | 1986 |
The diagnosis and management of paroxysmal trigeminal neuralgia in association with a temporomandibular joint dysfunction.
Topics: Arthritis, Rheumatoid; Autonomic Nerve Block; Carbamazepine; Dermatitis; Female; Humans; Indomethaci | 1974 |
Diphenylhydantoin for steroid-induced muscle weakness.
Topics: Arthritis, Rheumatoid; Humans; Male; Middle Aged; Muscular Diseases; Phenytoin; Prednisolone | 1973 |
Pentose-phosphate pathway of leucocytes.
Topics: Adult; Aged; Alcoholism; Anemia, Aplastic; Arthritis, Rheumatoid; Asthma; Diabetes Mellitus; Female; | 1971 |
[Vitamins and medicines. New and complicated relations].
Topics: Arthritis, Rheumatoid; Aspirin; Drug Combinations; Drug Interactions; Epilepsy; Humans; Phenytoin; P | 1972 |